0001655566-21-000002.txt : 20211123 0001655566-21-000002.hdr.sgml : 20211123 20211123092558 ACCESSION NUMBER: 0001655566-21-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20211123 DATE AS OF CHANGE: 20211123 EFFECTIVENESS DATE: 20211123 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Sermonix Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001655566 IRS NUMBER: 472551294 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-422178 FILM NUMBER: 211435153 BUSINESS ADDRESS: STREET 1: 3000 E. MAIN ST CITY: COLUMBUS STATE: OH ZIP: 43209 BUSINESS PHONE: (614) 864-4919 MAIL ADDRESS: STREET 1: 3000 E. MAIN ST CITY: COLUMBUS STATE: OH ZIP: 43209 FORMER COMPANY: FORMER CONFORMED NAME: Sermonix Pharmaceuticals, LLC DATE OF NAME CHANGE: 20151014 D 1 primary_doc.xml X0708 D LIVE 0001655566 Sermonix Pharmaceuticals, Inc. 3000 E. MAIN ST COLUMBUS OH OHIO 43209 (614) 864-4919 DELAWARE Sermonix Pharmaceuticals, LLC Corporation true Thomas Pfisterer 3000 E. Main St Columbus OH OHIO 43209 Director Anthony Wild 3000 E. Main St Columbus OH OHIO 43209 Executive Officer Director David Portman 3000 E. Main St Columbus OH OHIO 43209 Executive Officer Director Promoter Richard De Schutter 3000 E. Main St Columbus OH OHIO 43209 Director Michael Friedman 3000 E. Main St Columbus OH OHIO 43209 Director Elizabeth Garner 3000 E. Main St Columbus OH OHIO 43209 Director Miriam Portman 3000 E. Main St Columbus OH OHIO 43209 Executive Officer Promoter Elizabeth Attias 3000 E. Main St Columbus OH OHIO 43209 Executive Officer Paul Plourde 3000 E. Main St Columbus OH OHIO 43209 Executive Officer Barry Komm 3000 E. Main St Columbus OH OHIO 43209 Executive Officer Simon Jenkins 3000 E. Main St Columbus OH OHIO 43209 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2021-11-12 false true false 0 LIFESCI CAPITAL 168404 None None 250 W. 55 St Suite 3401 New York NY NEW YORK 10019 NY NEW YORK false 40225000 40225000 0 false 9 2220000 0 0 The Company will use the proceeds for general working capital purposes, including but not limited to employee salaries. false Sermonix Pharmaceuticals, Inc. David Portman David Portman President 2021-11-22